Determination of compliance deficiencies of hemodialysis patients

Abstract

Chronic renal failure, a serious disease that is increasing day by day worldwide, causes irreversible nephron loss. In addition, chronic renal failure can lead to complications such as cardiovascular diseases, anemia, and bone metabolism diseases when not controlled. Based on Roy's theory, this study aimed to determine patients' compliance with HD treatment for the first step of the disease and fluid control to provide care. Patients 18 years or older who had the cognitive ability to answer the questions, had been receiving HD treatment for at least six months, had ESRD, could communicate, and voluntarily agreed to participate were included in the study. The "Patient information form," "Fluid Control Scale on Hemodialysis Patients (FCSHP)," and " End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ)" prepared by the researcher were used to collect the data. The FCSHP sub-dimension mean scores of the individuals included in the study were 18.95±2.88 in the knowledge dimension, 22.90±6.89 in the behavior dimension, and 8.63±3.31 in the attitude dimension, respectively. FCSHP's total mean score was found to be 50.48±10.46. The mean score of ESRD-AQ sub-dimension HD participation was 538.12±91.75, drug compliance was 185.17±27.17, fluid compliance was 121.96±59.33, diet compliance was 124.64±58.35, and ESRD-AQ total score was 969.91±180.12. As a result of this study, fluid adaptation and disease adaptation of hemodialysis patients are at a reasonable level. It was determined that the adaptation to the disease increased more in patients who moved from the knowledge dimension to the behavior and attitude dimension in fluid adaptation. In line with these results, it can be recommended that the disease adaptation of hemodialysis patients should be ensured with training and counseling after diagnosis, their adaptation should be evaluated intermittently, and the missing dimensions should be supported individually according to the Roy Adaptation Model.

Keywords

• ESRD
• Hemodialysis
• Patient
• Compliance
• Nephrology

References

1. Ammirati AL. Chronic kidney disease. Rev Assoc Med Bras (1992). 2020; 66: 03-09. https://doi:10.1590/1806-9282.66.S1.3. PMID: 31939529
2. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017; 389: 1238-1252. https://doi.org/10.1016/S0140-6736(16)32064-5. PMID: 27887750
3. Zadeh KK, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021; 398: 786-802. https://doi:10.1016/S0140-6736(21)00519-5. PMID: 34175022
4. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bulletin of the World Health Organization. 2018; 96(6): 414-22. https://doi:10.2471/BLT.17.206441. PMID: 29904224
5. Masakane I, Taniguchi M, Nakai S, et al. Annual Dialysis Data Report 2016, JSDT Renal Data Registry. Renal Replacement Therapy. 2018; 4(1): 4-45. https://doi.org/10.1186/s41100-018-0183-6.
6. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981): 1975-1982. https://doi:10.1016/S0140-6736(14)61601-9. PMID: 25777665
7. Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Management. 2010;39(3):477-485. https://doi:10.1016/j.jpainsymman.2009.08.008.
8. Horigan AE, Schneider SM, Docherty S, Barroso J. The experience and self management of fatigue in hemodialysis patients. Nephrol Nurs J. 2013; 40(2): 113-123. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703392/. PMID: 23767335

9. Chou JA, Kalantar-Zadeh K. Volume balance and intradialytic ultrafiltration rate in the hemodialysis patient. Curr Heart Fail Rep. 2017; 14(5): 421-427. https://doi:10.1007/s11897-017-0356-6. PMID: 28803369
10. Beerappa H, Chandrababu R. Adherence to dietary and fluid restrictions among patients undergoing hemodialysis: An observational study. Clinical Epidemiology and Global Health. 2019; 7: 127-130. https://doi.org/10.1016/j.cegh.2018.05.003.
11. Günalay S, Taşkıran E, Mergen H. Evaluation of dietary and fluid restriction non-adherence in patients on hemodialysis. Florence Nightingale Journal of Medicine. 2017; 3: 9-14. https://doi:10.5606/fng.btd.2017.003.
12. Naalweh KS, Barakat MA, Sweileh MW, et al. Treatment adherence and perception in patients on maintenance hemodialysis: a cross - sectional study from Palestine. BMC Nephrology. 2017; 18: 178. https://doi:10.1186/s12882-017-0598-2. PMID: 28558719
13. Afaj C. Fluid and dietary restriction’s efficacy on chronic kidney disease patients in hemodialysis. Rev Bras Enferm. 2015; 68: 842-850. https://doi:10.1590/0034-7167.2015680622i.
14. Efe D, Kocaöz S. Adherence to diet and fluid restriction of individuals on hemodialysis treatment and affecting factors in Türkiye. Japan J Nurs Sci. 2015; 12(2): 113-123. https://doi.org/10.1111/jjns.12055.
15. Alikari V, Tsironi M, Matziou V, et al. The impact of education on knowledge, adherence and quality of life among patients on haemodialysis. Qual Life Res. 2019; 28(1): 73-83. https://doi:10.1007/s11136-018-1989-y.
16. Kutlu FY, Ok E. Psychometrıc propertıes of Turkısh versıon of the End Stage Renal Dısease Adherence Questıonnaıre. Acıbadem University Health Sciences Journal. 2020;(3):427-437. https://doi.org/10.31067/0.2019.129.
17. Rosner F. Patient non-compliance: causes and solutions. The Mount Sinai Journal of Medicine. 2006; 73: 553-9. https://pubmed.ncbi.nlm.nih.gov/16568197/.
18. Dąbrowska-Bender M, Dykowska G, Żuk W, et al. The impact on quality of life of dialysis patients with renal insufficiency. Patient Prefer Adherence. 2018; 12: 577-583. https://doi:10.2147/PPA.S156356.
19. Davison SN, Jhangri GS. Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis Patients. Journal of Pain and Symptom Management. 2010; 39(3): 477-485. https://doi:10.1016/j.jpainsymman.2009.08.008.
20. Roy C. The Roy Adaptation Model. 3rd ed. Upper Saddle River: Pearson Prentice Hall Health New Jersey, 2009:35-50. https://scholar.google.com/scholar_lookup?title=The+Roy+adaptation+model&publication_year=2009.
21. Roy C. Extending the Roy Adaptation Model to meet changing global needs. Nursing Science Quarterly. 2011b; 24(4): 345-351. https://doi:10.1177/0894318411419210.
22. Afrasiabifar A, Karimi Z, Hassani P. Roy’s Adaptation Model-based patient education for promoting the adaptation of hemodialysis patients. Iran Red Crescent Med J. 2013; 15(7): 566-572. https://doi:10.5812/ircmj.12024.
23. Marudhar M, Josfeena M. Roy’s Adaptation Model of nursing. Int J Sci Dev Res. 2019; 4(1): 283-287. https://www.ijsdr.org/papers/IJSDR1901049.pdf.
24. Vicdan AK, Karabacak BG. Effect of treatment education based on the Roy Adaptation Model on adjustment of hemodialysis patients. Clinical Nurse Specialist. 2016; 30(4): E1-E13. https://doi:10.1097/NUR.0000000000000215.
25. Frazão CMF, Fernandes MI, Nunes MD, et al. Components of a Roy’s Adaptation Model in patients undergoing hemodialysis. Rev Gaúcha Enferm. 2013; 34(4): 45-52. https://doi:10.1590/s1983-14472013000400006.
26. Nobahar M, Saffari M, Babamohamadi H, et al. The effect of a care plan based on the Roy Adaptation Model on general health in hemodialysis patients: a randomized controlled clinical trial. J Ren Inj Prev. 2020: 1-11. https://doi:10.34172/jrip.2020.11.
27. Abo Deif H, Elsawi K, Selim M, NasrAllah M. Effect of an educational program on adherence to therapeutic regimen among chronic kidney disease stage 5 (CKD5) patients under maintenance hemodialysis. Journal of Education and Practice. 2015; 6(5): 21-33. https://doi:10.4172/2167-1168.C1.019.
28. Sharaf YA. The impact of educational interventions on hemodialysis patients' adherence to fluid and sodium restrictions. Journal of Nursing and Health Science. 2016; 5(3): 50-60. https://doi:10.9790/7388-0603025060.
29. KimY, Evangelista LS, Phillips LR, et al. The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ): testing the psychometric properties in patients receiving in-center hemodialysis. Nephrol Nurs J. 2010; 37(4): 377-93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077091/pdf/nihms258802.pdf.
30. Ok E, Kutlu FY. Psychometric properties of Turkish version of the end stage renal disease adherence questionnaire. Acıbadem University Health Sciences Journal. 2019a; 10(3): 427-437. https://doi.org/10.31067/0.2019.129.
31. Albayrak Coşar A, Çınar Pakyüz S. Scale development study: Fluid control in hemodialysis patients. Jpn J Nurs Sci. 2016; 13(1): 174-82. https://doi:10.1111/jjns.12083.
32. Al-Khattabi GH. Prevalence of treatment adherence among attendance at hemodialysis in Makah. Int J Med Sci Public Health. 2014; 3(5): 592-8.